Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (13,830,084)	$ (8,864,329)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense	3,893,616	2,218,530
Depreciation and amortization	444,452	554,954
Changes in fair value of derivative liability	0	10,606
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	190,000	0
Bad debt recovery	(1,711)	0
Deferred Income Taxes	47,409	0
Prepaid expenses and other current assets	(271,149)	(192,009)
Accounts receivable	(25,012)	167,444
Inventory	(205,589)	(428,549)
Unearned revenues	216,515	346,912
Other assets	(53,035)	(22,986)
Accounts payable, accrued expenses and other liabilities	(1,658,952)	(905,094)
Net cash used in operating activities	(11,253,540)	(7,135,733)
Cash flows from investing activities:
Acquisition of property and equipment	(1,239,606)	(53,571)
Net cash used in investing activities	(1,239,606)	(53,571)
Cash flows from financing activities:
Proceeds from Stock Options Exercised	71,360	0
Proceeds from exercise of warrants	1,275,000	105,881
Net proceeds from issuance of common stock	5,630,625	2,730,262
Repayment of mortgage loan	(52,768)	(43,446)
Proceeds from notes payable	958,014	0
Repayment of notes payable	(163,192)	(81,015)
Change in warrant liabilities	0	(6,239)
Net cash provided by financing activities	7,719,039	2,705,443
Net decrease in cash and cash equivalents	(4,774,107)	(4,483,861)
Cash and cash equivalents at beginning of period	46,133,759	13,737,452
Cash and cash equivalents at end of period	41,359,652	9,253,591
Cash and cash equivalents of continuing operations at end of period	41,359,652
Supplemental Disclosure of Cash Flow Information:
Interest	93,100	95,700
Taxes	$ 0	$ 0